HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options    My Account    Help    


Top Stocks Set to Outperform
Over the Next 1 to 3 Months.

Click for your free picks >>

Quote:
Login Free Membership
Search:

Top Zacks Features
Free Membership
Premium Home
Zacks Rank
Equity Research
My Portfolio
Stock Screener
Profit Tracks
Mutual Funds
Options
Zacks Video
RSS Feed
Profit from the Pros

Subscription Services
Product Guide
Zacks Premium
Zacks Elite
Method for Trading
Chart Patterns Trader
Double Your Money
ETF Trader
Growth Trader
Options Trader
Small Cap Trader
Strategic Investor
Surprise Trader
Top 10 Stocks
Value Trader
Special Reports
Research Wizard

Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive

SLXP: Salix Pharmaceuticals Ltd - Stock News Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Company News |  Zacks Commentary
SALIX PHARMACEUTICALS LTD (NASD)
SLXP 23.50 0.04 (0.17%) Vol.  246,900 11.00 CST

Nov 24, 2009 BiomedReports: News and FDA Updates for Salix (NASDAQ:SLXP), TapImmune (OTC:TPIV), Walgreens (NYSE:WAG)
Nov 24, 2009 Salix Pharmaceuticals to Present at Piper Jaffray Conference
Nov 24, 2009 Salix Pharmaceuticals Sells 6.325 Million Common Shares
Nov 23, 2009 Salix Pharmaceuticals Sells $128.2 Mln in Shares - Down Fractionally
Nov 23, 2009 Salix Pharmaceuticals, Ltd. Completes Sale of 6.325 Million Shares of Common Stock
Nov 23, 2009 The Fortune Financial Coverage of New Alliance Bancshares Inc., Men'sWearhouse Inc., Microsoft Corp., Hercules Offshore Inc., News Corp.and Salix Pharmaceuticals Ltd
Nov 19, 2009 BiomedReports: News and FDA Updates for Salix (NASDAQ:SLXP), Sunesis (NASDAQ:SNSS), Synta (NASDAQ:SNTA)
Nov 19, 2009 OTC Stock Review: OTC Stock Review Stocks in Motion for Thursday, November 19, 2009 are Cyplasin Biomedical Ltd., Salix Pharmaceuticals, Ltd., Affymax Inc., and Delcath Systems, Inc.
Nov 19, 2009 Salix Pharmaceuticals Prices Common Share Offering
Nov 19, 2009 Salix Pharmaceuticals Up 99.3% Since SmarTrend's Buy Recommendation
Nov 18, 2009 Salix Pharmaceuticals, Ltd. Announces Pricing of a Public Offering of Common Stock
Nov 12, 2009 Salix Beats on Xifaxan Strength
Nov 12, 2009 Salix Pharmaceuticals Releases 3Q 2009 Results
Nov 11, 2009 Salix Pharmaceuticals Up 82.9% Since SmarTrend's Buy Recommendation
Nov 11, 2009 AnalystChoice.com Provides Analytical Coverage on BMS, TKC, DTG, ACH,CTB and SLXP
 
ZACKS COMMENTARY FOR SLXP
Nov 16, 2009 Zacks Equity Research: Report for SLXP
Nov 11, 2009 Zacks Blog: Salix Beats on Xifaxan Strength
Oct 30, 2009 Zacks Blog: Bearish MACD for Salix
Sep 29, 2009 Zacks Blog: Metozolv ODT Launch on Track
Sep 29, 2009 Zacks Blog: Salix Hopeful on New Indications
Sep 16, 2009 Zacks Blog: Zacks Analyst Blog Highlights: Genzyme Corp., Salix Pharmaceuticals, Walt Disney Co., Sunoco Logistics Partners LP and Theravance
Sep 15, 2009 Zacks Blog: Salix Scores on Rifaximin Data
Sep 14, 2009 Zacks Blog: Company News for September 14, 2009
Sep 09, 2009 Zacks Blog: Good News for Salix
Aug 25, 2009 Zacks Blog: Salix Drug Gets Priority Status
May 13, 2009 Zacks Blog: SunPower Corp., Salix Pharmaceuticals, Acadia Pharmaceuticals, Biovail, Allergan
May 13, 2009 Bear of the Day: Salix Pharmaceuticals (SLXP)

 
About Zacks | Advertise | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2009 Zacks Investment Research